Article
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study
1 Jan 2016
Abstract excerpt
PURPOSE: Telomere attrition and corresponding cellular senescence of the retinal pigment epithelium contribute to the changes of age-related macular degeneration. Activation of the enzyme telomerase can add telomeric DNA to retinal pigment epithelium chromosomal ends and has been proposed as a treatment for age-related macular degeneration. We report the use of a small molecule, oral telomerase activator (TA)-65...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
